Akèy › Kansè nan tete › Lwizyàn › New Orleans
Etid klinik pou Kansè nan tete nan New Orleans, LA
11 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote New Orleans (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University Medical Center New Orleans, New Orleans
- Touro Infirmary, New Orleans
- West Jefferson Medical Center, Marrero · 4 mi lwen
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Ochsner Clinic Foundation ( Site 0021), New Orleans
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- University Medical Center-New Orleans, New Orleans
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Ap rekriteFaz 1
- Ochsner Medical Center (OMC), New Orleans
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Care Access-Marrero, Marrero · 4 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- Touro Infirmary, New Orleans
- ak 1 plis
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- University Medical Center New Orleans, New Orleans
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Louisiana State University Health Sciences Center, New Orleans
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- Ochsner Medical Center Jefferson, New Orleans
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, New Orleans
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Ap rekriteEtid obsèvasyon
- Louisiana State University, New Orleans
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan New Orleans
- Kansè (tout kalite)12 etid
- Kansè ovè12 etid
- Kansè pwostat10 etid
- Kansè Endomèt9 etid
- Kansè Metastatik9 etid
- Kansè poumon9 etid
- Kansè Poumon ki pa ti selil9 etid
- Maladi kadyovaskilè9 etid
- Obèsite8 etid
- Maladi fwa steatotik8 etid
- Kansè kolorektal8 etid
- Fibrilasyon atriyal8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.